cd38 inhibitor synergy with nnmt inhibitor 5-amino-1mq nad+ inhibition counteracts tubular senescence and fibrosis in early stages of chronic kidney disease: Cell Reports Nicotinamide N-Methyltransferase in Cardiovascular Diseases:
Nicotinamide N Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice Scientific Reports Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control ScienceDirect Nicotinamide N Methyltransferase (NNMT) and Liver Cancer: From Metabolic Networks to Therapeutic Targets A systems approach to NAD+ restoration ScienceDirect Targeting CD38 dependent NAD+ metabolism to mitigate multiple organ fibrosis ScienceDirect
Pay in 4 interest-free payments of $7.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





